1 August 2005
Phogen enters into a Technology Commercialisation Agreement with Cancer Research Technology
10 May 2005
Cancer Research Technology announces the appointment of Dr Phil L’Huillier as Director of Business Management
10 January 2005
Xenova Group plc: Xenova Licenses TA-CIN to Cancer Research Technology
|
